Loading…
Comparative activity of piperacillin/tazobactam against 5625 isolates from hospitalised patients
The comparative activities of piperacillin/tazobactam and other antibiotics against 5625 Gram-negative and Gram-positive bactena freshly isolated from hospitalized patients was examined. The percentage of Enterobacteriaceae susceptible to piperacillin/tazobactam, ceftazidime, imipenem and ciprofloxa...
Saved in:
Published in: | Journal of antimicrobial chemotherapy 1996, Vol.37 (2), p.285-293 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The comparative activities of piperacillin/tazobactam and other antibiotics against 5625 Gram-negative and Gram-positive bactena freshly isolated from hospitalized patients was examined. The percentage of Enterobacteriaceae susceptible to piperacillin/tazobactam, ceftazidime, imipenem and ciprofloxacin was very similar and varied from 81% to 84% in the Enterobacteriaceae with inducible type 1 β-lactamases and from 93 to 97% in the non-inducible organisms. Piperacillin/tazobactam was similar in activity to ceftazidime against Pseudomonas aeruginosa and more active than imipenem or ciprofloxacin. Piperacillin/tazobactam is more active than ceftazidime against Gram-positive bacteria (staphylococci, enterococci) and seems to be a promising antibiotic for nosocomial infections. |
---|---|
ISSN: | 0305-7453 1460-2091 |
DOI: | 10.1093/jac/37.2.285 |